Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, delivered an adjusted loss per share of 20 cents in second-quarter 2024, narrower than the year-ago quarter's loss of 26 cents per share. The adjusted loss per share beat the Zacks Consensus Estimate by 16.7%. The company's GAAP loss per share was 64 cents in the quarter, wider than the year-ago period's loss of 28 cents. Revenues in Detail PacBio registered revenues of $36 million in the second quarter, down 24.3% year over year. T ...